A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer
ACS Nano · 24.03.2026 · 20 (11) · 9440-9458
DOI: 10.1021/acsnano.5c21831 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.03.2026. Verfasst von Yunhao Gao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and P…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Immunotherapy, Selenium, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Chin…
- Department of Urology, Linyi People's Hospital, Shandong Second Medical University, Linyi 276000, China.
- Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
ORCID-Profile: Chun Xu, Zheng Cao, Haihua Xiao, Nianzeng Xing
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Medical Sciences
Zitieren
APA
Gao, Y., Yang, F., Yin, L., Wang, W., Wang, K., Zhang, H., Zhang, Z., Chen, D., Pan, K., Liu, W., Jia, B., Xu, C., Cao, Z., Chen, A., Pei, D., Xiao, H., Shao, Z., & Xing, N. (2026). A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer. ACS Nano, 20(11), 9440-9458. https://doi.org/10.1021/acsnano.5c21831
Vancouver
Gao Y, Yang F, Yin L, Wang W, Wang K, Zhang H, et al. A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer. ACS Nano. 2026;20(11):9440-9458. doi:10.1021/acsnano.5c21831
BibTeX
@article{Gao2026,
author = {Gao, Yunhao and Yang, Feiya and Yin, Lu and Wang, Wenkuan and Wang, Kai and Zhang, Hanchen and Zhang, Zhen and Chen, Dong and Pan, Kehao and Liu, Wen and Jia, Bin and Xu, Chun and Cao, Zheng and Chen, Aolong and Pei, Delong and Xiao, Haihua and Shao, Zhiqiang and Xing, Nianzeng},
title = {A Redox-Responsive Selenium-Containing Nanomedicine Enables Dual Antioxidant System Inhibition to Overcome Platinum Resistance and Enhance Immunotherapy in Bladder Cancer},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {11},
pages = {9440--9458},
doi = {10.1021/acsnano.5c21831}
}
EUVIMED